Company Overview and News

 
Barclays-Standard Chartered? I Can’t Even… - WSJ

15h wsj
When an activist investor comes knocking, boards like to look busy—particularly if the activist is directly funded by a handful of your existing shareholders.

 
Barclays and Standard Chartered merger speculation gets a cool reception

21h telegraph.co.uk
The City has questioned the rationale of any mega-merger between Barclays and FTSE 100 banking rival Standard Chartered, following speculation that Barclays was considering merger options.

 
Deals of the day-Mergers and acquisitions

21h reuters
May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:

 
UPDATE 1-UK Stocks-Factors to watch on May 23

2018-05-23 reuters
May 23 (Reuters) - Britain’s FTSE 100 index is seen opening 19 points lower at 7,858 on Wednesday, according to CMC Markets, with futures down 0.46 percent ahead of the cash market open.

 
Barclays is reportedly looking at a potential merger with Standard Chartered

2018-05-23 cnbc
Barclays has spoken to its rival bank Standard Chartered about a potential merger but no formal or informal bid was made, the Financial Times reported on Wednesday, citing two unnamed sources.

 
Fingerprint-based payments provider Touche inks deal with OCBC - Channel NewsAsia

2018-05-23 channelnewsasia
SINGAPORE: Merchants with OCBC Bank could soon have the option of offering a fingerprint-based payments and loyalty programme system to its customers.

 
Why Hong Kong homebuyers should take note if city’s aggregate balance dips below HK$100 billion

2018-05-22 scmp
With several indicators suggesting Hong Kong dollar liquidity is becoming tighter, banks’ higher borrowing costs could translate into higher mortgage repayments for homeowners

 
Phillips 66 Is Cashing In On The Oil Spread

2018-05-21 seekingalpha
The refining company can take advantage of the $8 differential between West Texas Intermediate crude oil and Brent crude.

 
Standard Chartered PLC - Updates

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Trump Expected to Follow Through on Threat to Impose China Tariffs - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Top Image Systems' (TISA) CEO Brendan Reidy on Q4 2017 Results - Earnings Call Transcript

2018-05-17 seekingalpha
Top Image Systems Ltd (NASDAQ:TISA) Q4 2017 Earnings Conference Call May 17, 2018 10:00 AM ET

 
Tata Steel said to seek loan for Bhushan Steel asset purchase

2018-05-17 livemint
Mumbai: Tata Steel Ltd. is preparing a Rs11,500 crore ($1.7 billion) loan to help fund its purchase of assets from Bhushan Steel Ltd., people familiar with the matter said.

 
Egypt's Banque Misr hires Citi for $500 mln loan -sources

2018-05-17 reuters
DUBAI (Reuters) - Banque Misr, Egypt’s second largest bank, has mandated Citigroup (C.N) to arrange a $500 million syndicated loan, banking sources said, the latest sign of a pick-up in interest among international banks in lending to Egyptian borrowers.

 
Private equity managers express exit preference via Hong Kong IPOs, conference hears

2018-05-14 scmp
In Asia, exit values rose by a quarter in 2017 compared with the previous five-year average, to a near-record US$115 billion, with 710 exits completed

 
Construction stocks and ringgit likely to be focus

2018-05-11 thestar.com.my
PETALING JAYA: Amidst the easing of fears of political uncertainty, the performance of the ringgit and construction-related stocks is likely to be in focus when markets open on Monday.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...